AEGiS-UPI: Researcher suspended over AIDS study United Press InternationalImportant note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




Researcher suspended over AIDS study

United Press International; Saturday January 31 6:19 PM EST


LOS ANGELES, Jan. 31 (UPI) _ The Los Angeles County Health Department has placed its chief researcher on leave while trying to stem rumors that poor blacks would be unwittingly used in research on a vaccine for the AIDS virus.

The Los Angeles Times reports today that Dr. Peter Kerndt's proposed study would help lay the groundwork for later tests of an AIDS vaccine by the National Institutes of Health.

The vaccine study's administrators at NIH say Kerndt had proposed to study the behavior of heterosexual black women whose lifestyles make them "high risk" for contracting the AIDS virus.

Kerndt is also heading a study for the Center for Disease Control that tests people for exposure to the HIV virus.

Homeless Outreach Program Executive Director Mike Neely told the Times he expressed concern to county Supervisor Yvonne Brathwaite Burke that Kerndt would "sneak people in" to the controversial vaccine program after recruiting them for the CDC study.

Burke told county health officials she suspected Kerndt would use poor blacks from her district as "guinea pigs" in tests of a vaccine and called the study "scientific racism."

Health department officials suspended both studies Friday amid allegations that Kerndt did not request approval for the project through the proper channels and did not disclose that an AIDS vaccine could contain components of the HIV virus.

But the Times also obtained interdepartmental correspondence suggesting that Kerndt's supervisors knew all about the project, but may have failed to inform the department's upper management.


980131
UP980113


Copyright © 1998 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .